Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? (Q37471532)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 2009

edit

Language	Label	Description	Also known as
English	Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?	scientific article published on April 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

main subject

toxicity

0 references

author

Martine Piccart-Gebhart

series ordinal

4

object named as

Martine Piccart-Gebhart

0 references

Evandro de Azambuja

series ordinal

1

object named as

Evandro de Azambuja

0 references

Philippe L. Bedard

object named as

Philippe L Bedard

series ordinal

2

0 references

author name string

Thomas Suter

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

publication date

1 April 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

published in

Targeted oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

volume

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

page(s)

77-88

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

cites work

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology and diagnosis of cancer drug induced cardiomyopathy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity of trastuzumab in clinical practice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac dysfunction in the trastuzumab clinical trials experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letter Regarding Article by Okoshi et al, “Neuregulins Regulate Cardiac Parasympathetic Activity: Muscarinic Modulation of β-Adrenergic Activity in Myocytes From Mice With Neuregulin-1 Gene Deletion”

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ErbB2 is essential in the prevention of dilated cardiomyopathy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity profile of trastuzumab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Requirement for neuregulin receptor erbB2 in neural and cardiac development

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Jumping higher: is it still possible? The ALTTO trial challenge

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Herceptin and the heart--a molecular modifier of cardiac failure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The new generation of breast cancer clinical trials: the right drug for the right target

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuation of trastuzumab beyond disease progression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab and breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19418111

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11523-009-0112-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

PubMed publication ID

19418111

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19418111

retrieved

20 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37471532&oldid=2214332482"